BNP Paribas Arbitrage SNC cut its holdings in shares of Vericel Co. () by 46.9% in the second quarter, reports.

Source: https://www.americanbankingnews.com/2023/11/30/bnp-paribas-arbitrage-snc-has-1-16-million-holdings-in-vericel-co-nasdaqvcel.html

Finally, Advisors Asset Management Inc. grew its stake in shares of Vericel by 6.7% during the 3rd quarter.

Source: https://www.etfdailynews.com/2023/04/16/new-york-state-common-retirement-fund-acquires-19492-shares-of-vericel-co-nasdaqvcel/

Looking ahead, you can expect Vericel to launch NexoBrid in Q2 next year (i.e., just a few months from now).

Source: https://seekingalpha.com/article/4567239-vericel-aggressive-growth-in-2023?source=feed_all_articles

The advancements made by Vericel are heartening, and the robust performance of MACI at the end of the year signals a bright outlook.

Source: https://seekingalpha.com/article/4591772-vericel-corporation-vcel-promising-future-advanced-cell-therapies?source=feed_all_articles

Vericel beats Kodiak Sciences on 7 of the 13 factors compared between the two stocks.

Source: https://www.etfdailynews.com/2023/12/20/reviewing-kodiak-sciences-nasdaqkod-and-vericel-nasdaqvcel/